243 related articles for article (PubMed ID: 18668202)
1. Pleiotropic effects of sphingolipids in skeletal muscle.
Bruni P; Donati C
Cell Mol Life Sci; 2008 Nov; 65(23):3725-36. PubMed ID: 18668202
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.
Nikolova-Karakashian MN; Reid MB
Antioxid Redox Signal; 2011 Nov; 15(9):2501-17. PubMed ID: 21453197
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology.
Tan-Chen S; Guitton J; Bourron O; Le Stunff H; Hajduch E
Front Endocrinol (Lausanne); 2020; 11():491. PubMed ID: 32849282
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipid metabolism and its role in the skeletal tissues.
Khavandgar Z; Murshed M
Cell Mol Life Sci; 2015 Mar; 72(5):959-69. PubMed ID: 25424644
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid metabolites in neural signalling and function.
Colombaioni L; Garcia-Gil M
Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.
Roszczyc-Owsiejczuk K; Zabielski P
Front Endocrinol (Lausanne); 2021; 12():635175. PubMed ID: 33815291
[TBL] [Abstract][Full Text] [Related]
7. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate axis: a new leader actor in skeletal muscle biology.
Donati C; Cencetti F; Bruni P
Front Physiol; 2013 Nov; 4():338. PubMed ID: 24324439
[TBL] [Abstract][Full Text] [Related]
9. The role of sphingolipids in the control of skeletal muscle function: a review.
Sabbadini RA; Danieli-Betto D; Betto R
Ital J Neurol Sci; 1999 Dec; 20(6):423-30. PubMed ID: 10937863
[TBL] [Abstract][Full Text] [Related]
10. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
11. Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity.
Bielawiec P; Harasim-Symbor E; Konstantynowicz-Nowicka K; Sztolsztener K; Chabowski A
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32859125
[TBL] [Abstract][Full Text] [Related]
12. Impact of insulin deprivation and treatment on sphingolipid distribution in different muscle subcellular compartments of streptozotocin-diabetic C57Bl/6 mice.
Zabielski P; Blachnio-Zabielska A; Lanza IR; Gopala S; Manjunatha S; Jakaitis DR; Persson XM; Gransee J; Klaus KA; Schimke JM; Jensen MD; Nair KS
Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E529-42. PubMed ID: 24368672
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipid metabolism in cancer signalling and therapy.
Ogretmen B
Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025
[TBL] [Abstract][Full Text] [Related]
14. Altering sphingolipid composition with aging induces contractile dysfunction of gastric smooth muscle via K(Ca) 1.1 upregulation.
Choi S; Kim JA; Kim TH; Li HY; Shin KO; Lee YM; Oh S; Pewzner-Jung Y; Futerman AH; Suh SH
Aging Cell; 2015 Dec; 14(6):982-94. PubMed ID: 26288989
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids in High Fat Diet and Obesity-Related Diseases.
Choi S; Snider AJ
Mediators Inflamm; 2015; 2015():520618. PubMed ID: 26648664
[TBL] [Abstract][Full Text] [Related]
16. Modulation of sphingolipid metabolism with calorie restriction enhances insulin action in skeletal muscle.
Obanda DN; Yu Y; Wang ZQ; Cefalu WT
J Nutr Biochem; 2015 Jul; 26(7):687-95. PubMed ID: 25771159
[TBL] [Abstract][Full Text] [Related]
17. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
18. [The role of sphingolipids in selected cardiovascular diseases].
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Chabowska A; Łukaszuk B; Żendzian-Piotrowska M
Postepy Hig Med Dosw (Online); 2013 Sep; 67():1018-26. PubMed ID: 24088546
[TBL] [Abstract][Full Text] [Related]
19. Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction.
Sassoli C; Formigli L; Bini F; Tani A; Squecco R; Battistini C; Zecchi-Orlandini S; Francini F; Meacci E
J Cell Mol Med; 2011 Nov; 15(11):2498-511. PubMed ID: 21199328
[TBL] [Abstract][Full Text] [Related]
20. Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways.
Lambernd S; Taube A; Schober A; Platzbecker B; Görgens SW; Schlich R; Jeruschke K; Weiss J; Eckardt K; Eckel J
Diabetologia; 2012 Apr; 55(4):1128-39. PubMed ID: 22282161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
